Muutke küpsiste eelistusi

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets 1st ed. 2017 [Kõva köide]

Edited by , Edited by , Edited by , Edited by
  • Formaat: Hardback, 542 pages, kõrgus x laius: 235x155 mm, kaal: 9575 g, 26 Illustrations, color; 12 Illustrations, black and white; XIV, 542 p. 38 illus., 26 illus. in color., 1 Hardback
  • Sari: Advances in Neurobiology 15
  • Ilmumisaeg: 17-Jul-2017
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3319571915
  • ISBN-13: 9783319571911
Teised raamatud teemal:
  • Kõva köide
  • Hind: 261,79 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 307,99 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 542 pages, kõrgus x laius: 235x155 mm, kaal: 9575 g, 26 Illustrations, color; 12 Illustrations, black and white; XIV, 542 p. 38 illus., 26 illus. in color., 1 Hardback
  • Sari: Advances in Neurobiology 15
  • Ilmumisaeg: 17-Jul-2017
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3319571915
  • ISBN-13: 9783319571911
Teised raamatud teemal:
Provides a timely overview of critical advances in molecular and cellular neurobiology, covers key methodologies driving progress, and highlights key future directions for research on neuronal injury and neurodegeneration relevant to neuronal brain pathologies. The editors bring together contributions from internationally recognized workers in the field to provide an up to date account of how and why molecular and cellular neurobiology is such an important area for clinical neuroscience. Understanding the molecular aspects of a number of neurodegenerative conditions such as Parkinson's or Alzheimer's disease for the purpose of improving patient management remains a major challenge of neurobiology be it from the basic or clinical perspective. A strategic evaluation of research contributions and the power of modern methods will help advance knowledge over the next years.
Part I Major Neurodegenerative Conditions
1 Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons
3(28)
Anne E. Harasta
Lars M. Ittner
2 Clinical Aspects of Alzheimer's Disease
31(24)
Fiona Kumfor
Glenda M. Halliday
Olivier Piguet
3 Parkinson's Disease: Basic Pathomechanisms and a Clinical Overview
55(38)
Alastair Noyce
Rina Bandopadhyay
4 Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets
93(36)
Dean J. Wright
Thibault Renoir
Laura J. Gray
Anthony J. Hannan
5 The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers
129(34)
Lynette J. Tippett
Henry J. Waldvogel
Russell G. Snell
Jean-Paul Vonsattel
Anne B. Young
Richard L.M. Faull
6 Motoneuron Disease: Basic Science
163(28)
Hristelina Ilieva
Nicholas J. Maragakis
7 Motoneuron Disease: Clinical
191(20)
Hristelina Ilieva
Nicholas J. Maragakis
8 Multiple Sclerosis: Basic and Clinical
211(44)
Katherine Buzzard
Wing Hei Chan
Trevor Kilpatrick
Simon Murray
Part II Other Neurological Conditions
9 Schizophrenia: Basic and Clinical
255(26)
Joseph T. Coyle
10 Stroke: Basic and Clinical
281(14)
Tarvinder P. Singh
Jonathan R. Weinstein
Sean P. Murphy
11 Epileptic Encephalopathies as Neurodegenerative Disorders
295(22)
Ingo Helbig
Markus von Deimling
Eric D. Marsh
12 Neurodegeneration and Pathology in Epilepsy: Clinical and Basic Perspectives
317(18)
Jordan S. Farrell
Marshal D. Wolff
G. Campbell Teskey
13 Prion Diseases
335(30)
Benjamin C. Whitechurch
Jeremy M. Welton
Steven J. Collins
Victoria A. Lawson
14 Leukodystrophy: Basic and Clinical
365(18)
Gerald V. Raymond
15 Traumatic Brain Injury as a Trigger of Neurodegeneration
383(20)
Victoria E. Johnson
William Stewart
John D. Arena
Douglas H. Smith
Part III Key Background and Key Technologies
16 Cell Death Mechanisms of Neurodegeneration
403(24)
Jing Fan
Ted M. Dawson
Valina L. Dawson
17 Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies
427(24)
Alexei Verkhratsky
Robert Zorec
J.J. Rodriguez
Vladimir Parpura
18 Advances in Neuroimaging for Neurodegenerative Disease
451(28)
Michele Veldsman
Natalia Egorova
19 Gene Linkage and Systems Biology
479(12)
Mark R. Cookson
20 Biomarkers in Neurodegenerative Diseases
491
Andreas Jeromin
Robert Bowser
Erratum to 1(528)
Index 529